Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Shapiro

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 28, 2023
Acute Treatment with the M-Channel (K<sub>v</sub>7, KCNQ) Opener Retigabine Reduces the Long-Term Effects of Repetitive Blast Traumatic Brain InjuriesFabio A Vigil, Hindiael Belchior, Vladislav Bugay, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 5, 2021
Neuroprotective Roles of the Adenosine A<sub>3</sub> Receptor Agonist AST-004 in Mouse Model of Traumatic Brain InjuryEda Bozdemir, Fabio A Vigil, Sang H Chun, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 6, 2019
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K<sup>+</sup> currents in neuronsFabio A Vigil, Eda Bozdemir, Vladislav Bugay, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 28, 2023
Acute Treatment with the M-Channel (K<sub>v</sub>7, KCNQ) Opener Retigabine Reduces the Long-Term Effects of Repetitive Blast Traumatic Brain InjuriesFabio A Vigil, Hindiael Belchior, Vladislav Bugay, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 5, 2021
Neuroprotective Roles of the Adenosine A<sub>3</sub> Receptor Agonist AST-004 in Mouse Model of Traumatic Brain InjuryEda Bozdemir, Fabio A Vigil, Sang H Chun, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 6, 2019
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K<sup>+</sup> currents in neuronsFabio A Vigil, Eda Bozdemir, Vladislav Bugay, et al.
Pageof 7